Trinity Biotech TRIB
NASDAQ TRIB
$10.94 -0.07 (-0.64%)
At close: Aug 20, 2026 · 1:08 PM UTC

Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024)

Trinity Biotech (TRIB) posted Consolidated Net Income of -$573000.0 for Q4 2024, up 88.13% sequentially from -$4.8 million in Q3 2024, and down 19000.0% YoY from N/an in Q1 2024.

Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024) Analysis & Trends

Trinity Biotech has reported Consolidated Net Income for 16 years, with the latest figure at -$573000.0 in Q4 2024.

  • Quarterly Consolidated Net Income fell 19000.0% year-over-year to -$573000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$5.4 million (up 65.38% YoY) and the FY2025 annual result came in at -$37.4 million, down 6422.86% from the prior year.
  • Consolidated Net Income advanced to -$573000.0 in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $12.4 million in Q2 2023 and troughed at -$15.0 million in Q4 2020.
  • A 5-year average of $139250.0 and a median of $374000.0 in 2022 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2022 and 2024: Consolidated Net Income jumped 3696.55% in 2022, then sank 482800.0% in 2024.
  • Over 5 years, Consolidated Net Income stood at -$15.0 million in 2020, then jumped by 99.83% to -$25000.0 in 2021, then soared by 1444.0% to $336000.0 in 2022, then tumbled by 100.89% to -$3000.0 in 2023, then slumped by 19000.0% to -$573000.0 in 2024.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$573000.0, -$4.8 million, and -$7.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 905.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 1.04 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 201.00 Mn
10 Trinity Biotech 6.77 Mn 1.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -573,000.00
Sep 30, 2024 -4.83 Mn
Jun 30, 2024 -7.02 Mn
Mar 31, 2024 -3.18 Mn
Dec 31, 2023 -3,000.00
Sep 30, 2023 -1,000.00
Jun 30, 2023 12.36 Mn
Mar 31, 2023 496,000.00
Dec 31, 2022 336,000.00
Sep 30, 2022 1.04 Mn
Jun 30, 2022 412,000.00
Mar 31, 2022 791,000.00
Dec 31, 2021 -25,000.00
Sep 30, 2021 -29,000.00
Jun 30, 2021 527,000.00
Mar 31, 2021 4.39 Mn
Dec 31, 2020 -15.01 Mn
Sep 30, 2020 8.26 Mn
Jun 30, 2020 1.76 Mn
Mar 31, 2020 3.09 Mn